Non-uroselective and uroselective α1-adrenolitics in everyday urological practice – the duel
Keyword(s):
α1-adrenolitics are often considered the first-line treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) due to their quick onset of action, good efficacy and low frequency and severity of side effects. α1-adrenolitics are divided into non-uroselective and uroselective. The study compared two drugs, such as doxazosin and tamsulosin. The presented duel and its result may help in choosing the best treatment option for a specific patient with benign prostatic hyperplasia.